Style | Citing Format |
---|---|
MLA | Mousavi SJ, et al.. "Alginate-Based Nanocomposite Incorporating Chitosan Nanoparticles: A Dual-Drug Delivery System for Infection Control and Wound Regeneration." Journal of Drug Delivery Science and Technology, vol. 107, no. , 2025, pp. -. |
APA | Mousavi SJ, Heydari P, Javaherchi P, Kharazi AZ, Zarrabi A (2025). Alginate-Based Nanocomposite Incorporating Chitosan Nanoparticles: A Dual-Drug Delivery System for Infection Control and Wound Regeneration. Journal of Drug Delivery Science and Technology, 107(), -. |
Chicago | Mousavi SJ, Heydari P, Javaherchi P, Kharazi AZ, Zarrabi A. "Alginate-Based Nanocomposite Incorporating Chitosan Nanoparticles: A Dual-Drug Delivery System for Infection Control and Wound Regeneration." Journal of Drug Delivery Science and Technology 107, no. (2025): -. |
Harvard | Mousavi SJ et al. (2025) 'Alginate-Based Nanocomposite Incorporating Chitosan Nanoparticles: A Dual-Drug Delivery System for Infection Control and Wound Regeneration', Journal of Drug Delivery Science and Technology, 107(), pp. -. |
Vancouver | Mousavi SJ, Heydari P, Javaherchi P, Kharazi AZ, Zarrabi A. Alginate-Based Nanocomposite Incorporating Chitosan Nanoparticles: A Dual-Drug Delivery System for Infection Control and Wound Regeneration. Journal of Drug Delivery Science and Technology. 2025;107():-. |
BibTex | @article{ author = {Mousavi SJ and Heydari P and Javaherchi P and Kharazi AZ and Zarrabi A}, title = {Alginate-Based Nanocomposite Incorporating Chitosan Nanoparticles: A Dual-Drug Delivery System for Infection Control and Wound Regeneration}, journal = {Journal of Drug Delivery Science and Technology}, volume = {107}, number = {}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Mousavi SJ AU - Heydari P AU - Javaherchi P AU - Kharazi AZ AU - Zarrabi A TI - Alginate-Based Nanocomposite Incorporating Chitosan Nanoparticles: A Dual-Drug Delivery System for Infection Control and Wound Regeneration JO - Journal of Drug Delivery Science and Technology VL - 107 IS - SP - EP - PY - 2025 ER - |